Authors: DELONG AF DANIELS WD FREEMAN KB ALLERHEILIGEN SR OBERMEYER BD GOLDBERG MJ

Citation: Af. Delong et al., DISPOSITION OF C-14 AMESERGIDE AFTER ORAL-ADMINISTRATION IN MAN, The FASEB journal, 10(3), 1996, pp. 2634-2634

Authors: KASPER SC BONATE PL DELONG AF

Citation: Sc. Kasper et al., HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY FOR XANOMELINE, A SPECIFIC M-1 AGONIST, AND ITS METABOLITE IN HUMAN PLASMA, Journal of chromatography B. Biomedical applications, 669(2), 1995, pp. 397-403

Authors: MURPHY AT KASPER SC GILLESPIE TA DELONG AF

Citation: At. Murphy et al., DETERMINATION OF XANOMELINE AND ACTIVE METABOLITE, N-DESMETHYLXANOMELINE, IN HUMAN PLASMA BY LIQUID-CHROMATOGRAPHY ATMOSPHERIC-PRESSURE CHEMICAL-IONIZATION MASS-SPECTROMETRY, Journal of chromatography B. Biomedical applications, 668(2), 1995, pp. 273-280

Authors: DELONG AF JOHNSON JT OLDHAM SW PATEL BR HYSLOP DL

Citation: Af. Delong et al., DISPOSITION OF 14C DULOXETINE AFTER ORAL-ADMINISTRATION IN MAN, The FASEB journal, 9(4), 1995, pp. 691-691

Authors: MURPHY AT BONATE PL KASPER SC GILLESPIE TA DELONG AF

Citation: At. Murphy et al., DETERMINATION OF XANOMELINE IN HUMAN PLASMA BY IONSPRAY TANDEM MASS-SPECTROMETRY, Biological mass spectrometry, 23(10), 1994, pp. 621-625

Authors: DELONG AF BONATE PL GILLESPIE T HENRY DP SATTERWHITE JH

Citation: Af. Delong et al., ABSORPTION, DISTRIBUTION, METABOLISM, AND ELIMINATION OF RADIOLABELEDXANOMELINE IN HEALTHY MALE-SUBJECTS, Neurobiology of aging, 15, 1994, pp. 190000105-190000105